Paediatric Inflammatory Bowel Disease: A Multi-Stakeholder Perspective to Improve Development of Drugs for Children and Adolescents
Open Access
- 21 September 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 17 (2) , 249-258
Abstract
Background and Aims: Despite recent approvals for new drugs to treat adults with Crohn’s disease or ulcerative colitis, there are only two approved advanced treatment options [infliximab and adalimumab] for children with inflammatory bowel disease [IBD]. There are many potential new therapies being developed for adult and paediatric IBD. Moreover, regulatory agencies in both the European Union and USA have processes in place to support the early planning and initiation of paediatric studies. Nevertheless, unacceptable delays in approvals for use of drugs in children persist, with an average 7-year gap, or longer, between authorization of new IBD drugs for adults and children.Methods: A 2-day virtual meeting was held during April 14–15, 2021 for multi-stakeholders [clinical academics, patient community, pharmaceutical companies and regulators] to discuss their perspectives on paediatric drug development for IBD.Results: The multi-stakeholder group presented, discussed and proposed actions to achieve expediting the approval of new drugs in development for paediatric IBD.Conclusions: Collaborative action points for all stakeholders are required to make progress and facilitate new drug development for children with IBD.Keywords
Funding Information
- European Federation of Pharmaceutical Industries and Associations
This publication has 39 references indexed in Scilit:
- Use of Placebo in Pediatric Inflammatory Bowel DiseasesJournal of Pediatric Gastroenterology and Nutrition, 2016
- Steps Toward Harmonization for Clinical Development of Medicines in Pediatric Ulcerative Colitis—A Global Scientific Discussion, Part 2Journal of Pediatric Gastroenterology and Nutrition, 2014
- Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committeeGut, 2014
- Epidemiology of pediatric inflammatory bowel disease: A systematic review of international trendsInflammatory Bowel Diseases, 2011
- Incidence, Prevalence, and Time Trends of Pediatric Inflammatory Bowel Disease in Northern California, 1996 to 2006The Journal of Pediatrics, 2010
- Natural history of Crohnʼs diseaseInflammatory Bowel Diseases, 2010
- What is the peak age for onset of IBD?Inflammatory Bowel Diseases, 2008
- Challenges in pediatric inflammatory bowel diseaseInflammatory Bowel Diseases, 2006
- Risk Factors for Initial Surgery in Pediatric Patients With Crohn’s DiseaseGastroenterology, 2006
- Brief Report: Psychosocial Adjustment in Adolescents with Inflammatory Bowel DiseaseJournal of Pediatric Psychology, 2005